FDA: Remdesivir (Veklury) Approval for the Treatment of COVID-19 – The Evidence for Safety and Efficacy
November 25, 2020 — Under FDA law, approval of a new drug requires substantial evidence of effectiveness and a demonstration […]
21 October 2020 — ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi […] NEW YORK and MAINZ, GERMANY, October 6, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation […] THOUSAND OAKS, Calif., Oct. 5, 2020 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced positive topline Phase 2 results from the CodeBreaK 100 clinical study, evaluating […] INDIANAPOLIS, Sept. 16, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced proof of concept data from an interim analysis […] FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — […] Nasal saline and corticosteroid sprays are pretty standard treatment for individuals battling chronic rhinosinusitis (CRS). They thin out thick mucus […] A study to evaluate the effect of an Electronic Medication Complete Communication (EMC2) Opioid Strategy on patients’ safe use of […] Preventable deaths are those that can be stymied by public health intervention, and deaths related to tobacco use are at […] The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease (EVD) compared to the […]Medications
ViiV Healthcare Announces Analysis Showing no Antiretroviral Therapy Interruptions Due to COVID-19 Across its Clinical Development Programme for Investigational, Long-Acting Cabotegravir and Rilpivirine
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer
Lilly Announces Proof of Concept Data for Neutralizing Antibody LY-CoV555 in the COVID-19 Outpatient Setting
FDA Approves Qdolo
Sinuses bothering you? Use those nasal sprays regularly
Study: EMC2 tools improved safe dosing of opioids but had no influence on actual use
Smoking cessation treatment targets adolescents
Investigational drugs reduce risk of death from Ebola virus disease